Overview

Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction and safety.
Phase:
PHASE1
Details
Lead Sponsor:
Huons Co., Ltd.